FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a topical composition containing a combination of natural salt or pure sodium chloride and glucose mixed in ratio 1:1-30 (wt/wt) as an active ingredient in an amount effective for treating bacterial vaginosis caused by Cardnerella vaginalis together with a pharmaceutically acceptable carrier.
EFFECT: invention provides the higher pharmacological activity.
4 cl, 4 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF MIXTURE OF SALT AND SUGAR FOR PREPARING DRUG USED FOR TREATMENT OF SYNDROME OF VAGINAL MUSCLE STRAIN OR COLEITIS XEROSIS IN MAMMAL | 2014 |
|
RU2613714C2 |
| LACTOBACILLUS CRISPATUS STRAIN FOR TREATMENT OR PREVENTION OF SEXUAL AND UROGENITAL INFECTIONS, SUCH AS VAGINOSIS AND CANDIDIASIS, AND USE THEREOF | 2013 |
|
RU2661102C2 |
| USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS | 2013 |
|
RU2667122C2 |
| EFFERVESCENT COMPOSITION IN SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR TREATING VAGINAL INFECTIONS | 2012 |
|
RU2587717C2 |
| VIRUCIDAL, BACTERICIDAL AND SPERMATOCIDAL SUPPOSITORIUM | 1994 |
|
RU2147431C1 |
| METHOD OF TREATMENT OF BACTERIAL VAGINOSIS | 2022 |
|
RU2805786C2 |
| USE OF TOTAROL AND PHARMACEUTICAL COMPOSITION CONTAINING TOTAROL | 2018 |
|
RU2812223C2 |
| COMPOSITION FOR MAINTAINING DOMINANCE OF LACTIC ACID BACILLI | 2020 |
|
RU2827718C2 |
| COMPOSITION FOR MAINTENANCE OF LACTOBACTERIA DOMINATION | 2015 |
|
RU2723015C2 |
| BACTERIUM LACTOBACILLUS RHAMNOSUS FOR THE TREATMENT OF, FOR EXAMPLE, BACTERIAL VAGINOSIS | 2016 |
|
RU2758109C2 |
